<p>Recent clinical practice guidelines for diabetes, obesity, cardiovascular disease (CVD) and chronic kidney disease (CKD) emphasise a holistic, person-centred approach to care. However, they do not include recommendations for the assessment of patient-reported outcomes (PROs), which would – dependent on the topic of guideline – be important for improving shared decision-making, patients’ concordance with guideline recommendations, clinical outcomes and health-related quality of life (HRQoL). The Taskforce of the Guideline Workshop discussed PROs in diabetes, obesity, CVD and CKD as well as the relevance of their inclusion in clinical practice guidelines for the management of these conditions.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline Workshop

  • Katharine Barnard-Kelly,
  • Tadej Battelino,
  • Frank C. Brosius,
  • Antonio Ceriello,
  • Francesco Cosentino,
  • James R. Gavin III,
  • Francesco Giorgino,
  • Jennifer Green,
  • Linong Ji,
  • Monika Kellerer,
  • Sue Koob,
  • Mikhail Kosiborod,
  • Nebojsa Lalic,
  • Nikolaus Marx,
  • Prashant Nedungadi,
  • Christopher G. Parkin,
  • Helena W. Rodbard,
  • René D. Rötzer,
  • Lars Rydén,
  • Wayne Huey-Herng Sheu,
  • Eberhard Standl,
  • Britta Tendal Jeppesen,
  • Pinar Topsever,
  • Per Olav Vandvik,
  • Christoph Wanner,
  • Oliver Schnell

摘要

Recent clinical practice guidelines for diabetes, obesity, cardiovascular disease (CVD) and chronic kidney disease (CKD) emphasise a holistic, person-centred approach to care. However, they do not include recommendations for the assessment of patient-reported outcomes (PROs), which would – dependent on the topic of guideline – be important for improving shared decision-making, patients’ concordance with guideline recommendations, clinical outcomes and health-related quality of life (HRQoL). The Taskforce of the Guideline Workshop discussed PROs in diabetes, obesity, CVD and CKD as well as the relevance of their inclusion in clinical practice guidelines for the management of these conditions.